Document is current
Any future updates will be listed below
-
Authors
Veatch, Joshua R.
Riddell, Stanley R. https://orcid.org/0000-0002-4688-9920
-
Funding
Funding for this research was provided by:
U.S. Department of Health ; Human Services | National Institutes of Health (P50 CA228944)
U.S. Department of Health ; Human Services | National Institutes of Health (CA 114536)
U.S. Department of Defense (W81XWH-20-1-0239)
U.S. Department of Health ; Human Services | National Institutes of Health (P50 CA228944)
- License Information
-
More Information
Article History
First Online: 17 July 2023
Competing interests
: S.R.R. is a co-founder of and holds equity in Lyell Immunopharma. J.R.V. and S.R.R. have received grant funding from and have intellectual property licensed to Lyell Immunopharma. J.R.V. and S.R.R. have received research support from Bristol Myers Squibb.
